Incorrect artwork version used during packaging operations – recall risk case study


Published on 08/01/2026

Case Study: Risk of Recall Due to Incorrect Artwork Version Used in Packaging Operations

In pharmaceutical manufacturing, maintaining compliance with regulatory requirements is paramount, especially when it comes to packaging and labeling. A deviation involving the use of an incorrect artwork version can lead not only to potential recalls but also to significant regulatory scrutiny. This article will walk through a case study surrounding a recent incident where an incorrect artwork version was used during packaging operations, detailing each stage from detection to corrective and preventive actions (CAPA) and lessons learned. By following the outlined strategy, professionals can enhance their inspection readiness and prevent similar issues from arising in the future.

If you want a complete overview with practical prevention steps, see this Packaging & Labeling Deviations.

Upon conclusion, readers will understand how to effectively investigate such a deviation, implement CAPA, and maintain compliance with

regulatory expectations set forth by agencies like the FDA, EMA, and MHRA.

Symptoms/Signals on the Floor or in the Lab

During routine packaging operations of a new product batch, operators noticed discrepancies in the labeling. Specifically, the artwork on the packaging containers did not match the approved specifications as found in the master batch record (MBR). This inconsistency was identified through a quality check process, which included a visual inspection of the printed labels against the predefined artwork samples.

Key signals observed included:

  • Operators reporting unclear or incorrect information on labels, such as dosage instructions and product identification.
  • Increased customer queries related to product discrepancies.
  • An uptick in quality alerts regarding packaging errors from distribution centers.

These signals indicated potential non-compliance with Good Manufacturing Practices (GMP) and warranted immediate attention to prevent further implications, including product recalls and regulatory action.

Likely Causes

The root causes of the deviation can be systematically categorized using the “5Ms” framework—Materials, Method, Machine, Man, and Measurement. Each category can provide insight into where the deviation may have originated.

Category Likely Cause
Materials Incorrect artwork files sourced for printing, possibly due to an error in file management or version control.
Method Inadequate procedures for artwork approval and verification prior to production.
Machine Potential malfunction in printing equipment leading to misalignment of printed labels.
Man Lack of training or awareness among packaging staff regarding the importance of artwork accuracy.
Measurement Failure to implement adequate measurement controls to verify artwork against specifications.
Pharma Tip:  Serialization mismatch detected during deviation review – regulatory reporting outcome

Immediate Containment Actions (first 60 minutes)

Immediate action is critical to contain a deviation like this. The following steps should be taken within the first hour following detection:

  1. Halt Packaging Operations: Stop all packaging processes that involve the artwork in question to prevent further distribution of incorrect products.
  2. Isolate Affected Batches: Identify and quarantine all affected batches in the warehousing or distribution areas to prevent them from reaching consumers.
  3. Notify Stakeholders: Inform key stakeholders, including the Quality Assurance (QA) team, operations management, and potentially regulatory authorities, about the situation.
  4. Document Everything: Ensure that all observations, actions taken, and communications are thoroughly documented to create a record for investigation and potential regulatory requirements.
  5. Assess the Impact: Quickly evaluate the extent of the issue, including how many products might be affected and any associated risks to consumers.

Investigation Workflow

A robust investigation workflow is essential for understanding the root cause of the deviation. This workflow should include the following steps:

  1. Data Collection: Gather all relevant documentation related to the artwork version, including approval records, batch records, and Change Control forms. Also, collect logs from printing equipment used during the production run.
  2. Interviews: Conduct interviews with personnel involved in the packaging process, including operators and quality control staff, to gain insights into the sequence of events.
  3. Analysis of Controls: Review the artwork approval process to determine if proper checks and balances were in place to prevent the incorrect version from being used.
  4. Comparative Analysis: Analyze the discrepancies between the incorrect artwork and the approved version to understand the scope of the deviation.

Throughout this investigation, evidence should be collected to ensure that there is clear documentation outlining both the facts of the case and the impact on patients and compliance. All findings must be summarized and presented for further analysis in the root cause analysis phase.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

Several root cause analysis tools can be employed to further diagnose the issues found during the investigation:

  • 5-Why Analysis: This tool is highly effective for digging deeper into issues by asking “why” multiple times until the fundamental cause is identified. It is best used for simple problems where a direct cause is apparent.
  • Fishbone Diagram (Ishikawa): Utilized to categorize different potential causes of a problem, making it easier to visualize and brainstorm potential failure modes within the “5Ms” framework. It is ideal for complex issues with multiple contributing factors.
  • Fault Tree Analysis (FTA): A top-down approach starting from the unwanted event and mapping back through potential causes. It is useful for determining the interdependencies of various factors and assessing the likelihood of failures.
Pharma Tip:  Serialization mismatch detected during artwork change – recall risk case study

Choosing the right tool depends on the complexity of the issue and the clarity of the initial findings. In this case, a combination of the Fishbone Diagram and 5-Why analysis may be most effective for a comprehensive understanding of why the incorrect artwork was used.

CAPA Strategy (Correction, Corrective Action, Preventive Action)

When implementing the CAPA strategy, the following actions should be taken:

  1. Correction: Immediately correct the production records to reflect the accurate information, ensuring affected products are adequately logged and quarantined.
  2. Corrective Action: Develop and implement a robust review process for artwork approval, ensuring that only the latest versions are approved for production. This can include implementing advanced software solutions that track artwork versions and notify users of outdated files.
  3. Preventive Action: Establish regular training for employees involved in packaging and artwork management, coupled with periodic audits of the label and packaging processes to ensure compliance with established procedures.

Each action must be documented clearly, with timelines assigned and responsible personnel designated to ensure accountability.

Related Reads

Control Strategy & Monitoring (SPC/Trending, Sampling, Alarms, Verification)

A comprehensive control strategy is essential for monitoring the effectiveness of the implemented CAPA measures. This strategy should include:

  • Statistical Process Control (SPC): Implement SPC measures to monitor the performance of the printing and packaging process, allowing for real-time detection of anomalies in labels.
  • Regular Sampling: Conduct randomized sampling of production batches to verify that correct labels are being printed and applied correctly.
  • Alarm Systems: Develop alarm systems within production software to alert operators when incorrect files are accessed or used during labeling.
  • Verification Procedures: Establish verification protocols requiring dual sign-off from Quality Assurance personnel when artwork is checked against production samples.

Through careful implementation of monitoring practices, processes can be continuously evaluated for effectiveness, significantly reducing the risk of recurrence of similar deviations.

Validation / Re-qualification / Change Control Impact (When Needed)

Once corrective actions have been adopted, consider if validation or re-qualification of equipment or processes is warranted due to the deviation. Engagement in this phase ensures that once resolved, the issues do not surface again. Key considerations include:

  • Validation Needs: Reassess all validation documents to ensure that changes made during the CAPA process are adequately recorded, and impact assessments lead to updated validation requirements.
  • Re-qualification: For equipment that may have contributed to the mistake, re-qualification may be required to ensure it functions correctly within the updated procedures and processes.
  • Change Control: Implement a rigorous change control system to manage all future updates in materials, processes, or equipment to prevent deviations stemming from similar root causes.
Pharma Tip:  Tamper seal deviation during deviation review – regulatory reporting outcome

Inspection Readiness: What Evidence to Show

Being prepared for inspections by regulatory bodies like the FDA and EMA requires a clear documentation trail. Ensure to maintain the following:

  • Records: Maintain corrected production and packaging records that reflect accurate artwork usage.
  • Change Control Logs: Documentation showing how the situation was addressed, including process changes and employee training records.
  • Training Records: Keep comprehensive training records that confirm all packaging staff have received updated instructions regarding artwork verification processes.
  • Audits: Conduct internal audits post-resolution to verify compliance with new procedures and controls.

By establishing robust documentation practices, organizations can effectively convey compliance and readiness to inspectors, significantly mitigating the risks of regulatory non-compliance.

FAQs

What immediate actions should be taken upon discovering incorrect artwork?

The immediate actions include halting packaging, isolating affected batches, notifying stakeholders, documenting the deviation, and assessing the impact.

How can we ensure artwork accuracy during packaging?

Implement strong verification processes, including dual sign-offs for artwork checks, and ensure adequate training for packaging personnel.

What are the consequences of using incorrect artwork?

Consequences may include product recalls, regulatory non-compliance, customer complaints, and reputational damage.

Which root cause analysis tool is the most effective?

The effectiveness of a tool depends on the complexity of the deviation; for simple issues, a 5-Why analysis may suffice, while for complex cases, a Fishbone diagram might be more appropriate.

How do I document CAPA actions?

All CAPA actions should be documented in a clear manner, including timelines for implementation, responsible persons, and the outcomes of actions taken.

What role does training play in preventing artwork deviations?

Training ensures all personnel are aware of the importance of accurate artwork and are familiar with the updated processes to verify artwork before packaging.

How often should we conduct audits to maintain compliance?

Regular audits should be conducted with frequency based on risk assessments. At minimum, quarterly audits can help identify areas for improvement.

Is re-qualification necessary after a deviation?

Re-qualification may be necessary if the equipment or processes implicated in the deviation could lead to future issues. It ensures compliance with updated procedures.